Skip to main content

WAY-262611

BML-WN110

2 citations

  • BML-WN110-0005   —   5 mg
    $155.00
  • BML-WN110-0025   —   25 mg
    $624.00

Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only